๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Monitoring the treatment of paget's disease with etidronate

โœ Scribed by John A. Kanis

Publisher
Springer
Year
1984
Tongue
English
Weight
240 KB
Volume
36
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of etidronate (ehdp) in paget's dise
Use of etidronate (ehdp) in paget's disease of bone
โœ C. Conrad Johnston Jr; M. R. A. Khairi; P. J. Meunier ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 382 KB ๐Ÿ‘ 1 views

## Abstract Etidronate used in recommended doses (usually 5 mg/kg/day for 6 months) produces symptomatic improvement in approximately 60% of patients. The serum alkaline phosphatase and urinary hydroxyproline are reduced to about 50% of initial values. A sustained remission occurs in many patients